日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants

在健康受试者中评估阿西米尼与阿托伐他汀的药代动力学药物相互作用

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.1611
Hoch, Matthias; Weis, Wendy; Huth, Felix; Jamalapuram, Seshulatha; Quinlan, Michelle; Bandaru, Amarnath; Bellibas, Suleyman Eralp; Mirkou, Asmae; Kapoor, Shruti; Kakar, Shefali
发表日期：2026
文献求助 收藏

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease

单次输注MDCO-216（ApoA-1 Milano/POPC）可增加健康志愿者和稳定性冠状动脉疾病患者的ABCA1介导的胆固醇外流和前β1 HDL水平。

期刊:European Heart Journal-Cardiovascular Pharmacotherapy
影响因子:6.1
doi:10.1093/ehjcvp/pvv041
Kallend, D G; Reijers, J A A; Bellibas, S E; Bobillier, A; Kempen, H; Burggraaf, J; Moerland, M; Wijngaard, P L J
代谢
MDC
ABCA1
发表日期：2016
文献求助 收藏

Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trials

利用两项关键性 3 期临床试验的数据，对单次 1200 毫克奥利万星剂量进行群体药代动力学分析。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00176-15
Rubino, C M; Bhavnani, S M; Moeck, G; Bellibas, S E; Ambrose, P G
发表日期：2015
文献求助 收藏

Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys

重复输注apoA-IMilano/POPC对食蟹猴脂质、（载脂）脂蛋白和血清胆固醇外流能力的影响

期刊:Journal of Lipid Research
影响因子:4.1
doi:10.1194/jlr.M033779
Kempen, Herman J; Gomaraschi, Monica; Bellibas, S Eralp; Plassmann, Stephanie; Zerler, Brad; Collins, Heidi L; Adelman, Steven J; Calabresi, Laura; Wijngaard, Peter L J
代谢
发表日期：2013
文献求助 收藏